Recombinant Idiomarina loihiensis Prolipoprotein diacylglyceryl transferase (lgt)

Shipped with Ice Packs
In Stock

Description

Biological Role and Function

Lgt is the first enzyme in the bacterial lipoprotein biosynthesis pathway, modifying prolipoproteins by attaching a diacylglyceryl moiety to a conserved cysteine residue within the lipobox motif ([LVI][ASTVI][GAS]C) . This modification anchors lipoproteins to the bacterial membrane, enabling their roles in nutrient transport, cell envelope stability, and pathogenesis . Genetic depletion of Lgt in Escherichia coli and other Gram-negative bacteria leads to outer membrane permeabilization, increased antibiotic sensitivity, and cell death , underscoring its essentiality.

Applications in Research

Recombinant Lgt is utilized in:

  • Lipoprotein Biogenesis Studies: Investigating diacylglyceryl transfer mechanisms using in vitro assays .

  • Antibacterial Target Validation: Screening inhibitors that disrupt lipoprotein anchoring, a promising strategy against multidrug-resistant pathogens .

  • Structural Biology: Mapping membrane topology and conserved residues critical for enzymatic activity .

Table 2: Functional Insights from Studies

Study FocusFindingsSource
EssentialityLgt depletion in E. coli causes outer membrane defects and cell death .
Inhibitor DevelopmentMacrocyclic compounds (e.g., G2823) inhibit Lgt activity in vitro and show bactericidal effects .
Conserved ResiduesY26, N146, and G154 are critical for enzymatic function .
Subcellular LocalizationInner membrane protein with seven transmembrane domains .

Comparative Genomics

Idiomarina loihiensis Lgt shares homology with Lgt enzymes from E. coli and Acinetobacter baumannii, particularly in the signature motif required for phosphatidylglycerol binding . Unlike E. coli, I. loihiensis thrives in extreme environments, making its Lgt a model for studying enzyme adaptation .

Challenges and Future Directions

While recombinant Lgt enables mechanistic studies, challenges include:

  • Structural Resolution: No crystal structure exists for I. loihiensis Lgt, limiting inhibitor design .

  • Species-Specific Variations: Functional differences between Lgt orthologs may affect inhibitor cross-reactivity .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, we are happy to accommodate specific format requirements. Please indicate your desired format when placing your order, and we will fulfill your request.
Lead Time
Delivery times may vary depending on the purchasing method and location. Please consult your local distributors for specific delivery details.
Note: Our proteins are typically shipped with standard blue ice packs. If you require dry ice shipping, please inform us in advance, as additional charges will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend centrifuging the vial briefly prior to opening to ensure all contents settle at the bottom. Reconstitute the protein in deionized sterile water to a concentration between 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can be used as a reference.
Shelf Life
Shelf life is influenced by various factors including storage conditions, buffer components, temperature, and the protein's inherent stability.
Generally, liquid formulations have a shelf life of 6 months at -20°C/-80°C, while lyophilized forms have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type is determined during production. If you have a specific tag type in mind, please inform us, and we will prioritize developing it for your product.
Synonyms
lgt; IL0506; Phosphatidylglycerol--prolipoprotein diacylglyceryl transferase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-266
Protein Length
full length protein
Species
Idiomarina loihiensis (strain ATCC BAA-735 / DSM 15497 / L2-TR)
Target Names
lgt
Target Protein Sequence
MPSNDYWQFPAIDPVLFHIWGPLDIRWYGLAYIAAFAFAYFWGMRQTKTDPNWSKEEFSD LMFWGFIGVILGGRIGYTLFYHFDYFIDNPLYLFYIHEGGMSFHGGLLGVIAAMYLYARK KQRSFLQVGDFVAPLVPMGLFFGRIGNFINGELWGRAAEVPWAMYFPSGGPVPRHPSQLY EALLEGLLLFAVILWFQRKPRGVGAVSGLFLLGYGVARFIVEFFREPDAHLGLLSLGMSM GQWLTLPMIILGIILMVRAKKQLPTG
Uniprot No.

Target Background

Function
This enzyme catalyzes the transfer of the diacylglyceryl group from phosphatidylglycerol to the sulfhydryl group of the N-terminal cysteine of a prolipoprotein. This is the initial step in the formation of mature lipoproteins.
Database Links

KEGG: ilo:IL0506

STRING: 283942.IL0506

Protein Families
Lgt family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is the molecular structure of Idiomarina loihiensis Prolipoprotein diacylglyceryl transferase?

Idiomarina loihiensis Prolipoprotein diacylglyceryl transferase (lgt) is a transmembrane protein consisting of 266 amino acids with the UniProt accession number Q5R065 . The complete amino acid sequence begins with MPSNDYWQFPAIDPVLFHIWGPLDIRWYGLAYIAAFAFAYFWGMRQTKTDPNWSKEEFSD and continues through to the C-terminus GQWLTLPMIILGIILMVRAKKQLPTG . Based on studies of homologous Lgt proteins, particularly in E. coli, the protein likely contains seven transmembrane segments with the N-terminus facing the periplasm and the C-terminus facing the cytoplasm . The enzyme is classified with the EC number 2.4.99.-, indicating its role as a transferase .

What is the functional role of Lgt in bacterial physiology?

Prolipoprotein diacylglyceryl transferase (Lgt) catalyzes a critical step in bacterial lipoprotein biosynthesis by transferring a diacylglyceryl moiety to the conserved cysteine residue in the lipobox motif of prelipoproteins . This post-translational modification is essential for proper anchoring of lipoproteins to the bacterial membrane. In certain bacteria like E. coli, Lgt function is essential for viability, as demonstrated by complementation studies where chromosomal lgt expression was repressed . The enzyme's function is particularly critical in gram-negative bacteria where improper lipoprotein processing can lead to cell lysis, as seen with Lpp (Braun's lipoprotein) in E. coli .

Which domains and conserved regions are critical for Lgt enzymatic activity?

Lgt enzymes are characterized by a signature motif containing four invariant residues that are critical for function . Site-directed mutagenesis studies have identified several residues that are absolutely required for Lgt function, including Y26, N146, and G154, while residues R143, E151, R239, and E243 are important but not absolutely essential . The majority of these essential residues are located within the membrane, with the Lgt signature motif facing the periplasm . Recent research suggests that Lgt contains distinct "arm" and "head" domains that contribute to functional diversity among bacterial pathogens .

What are the optimal storage conditions for maintaining Recombinant I. loihiensis Lgt activity?

For optimal preservation of enzymatic activity, Recombinant Idiomarina loihiensis Lgt should be stored at -20°C in a Tris-based buffer containing 50% glycerol . For extended storage periods, conservation at -80°C is recommended . To prevent protein degradation, repeated freezing and thawing cycles should be avoided . Working aliquots can be safely maintained at 4°C for up to one week without significant loss of activity . The shelf life of the liquid form is generally 6 months at -20°C/-80°C, while the lyophilized form can be stored for up to 12 months at the same temperatures .

How can researchers perform functional complementation assays with I. loihiensis Lgt?

To assess the functional activity of I. loihiensis Lgt, researchers can employ complementation assays similar to those used for other Lgt homologs. The experimental design involves:

  • Creating a conditional lgt depletion strain in a model organism like E. coli where chromosomal lgt expression is repressed by growth in D-glucose

  • Introducing a plasmid expressing the I. loihiensis lgt gene under an IPTG-inducible promoter

  • Evaluating complementation by monitoring colony formation, growth kinetics, and cell morphology

  • Including appropriate controls such as empty vector and known functional Lgt homologs (e.g., E. coli Lgt)

This approach can determine whether I. loihiensis Lgt can functionally substitute for endogenous Lgt in a heterologous host . Success would be indicated by restoration of normal growth and cellular morphology in the absence of endogenous Lgt expression.

What analytical techniques are most effective for studying Lgt topology and membrane insertion?

Based on previous studies with Lgt homologs, the most effective techniques for investigating Lgt topology and membrane insertion include:

  • Substituted cysteine accessibility method (SCAM): This approach has been successfully used to determine the membrane topology of E. coli Lgt, revealing seven transmembrane segments with specific orientation of N and C termini .

  • Fusion reporter systems: Techniques employing PhoA (alkaline phosphatase) or GFP fusions at various positions along the protein sequence can help map membrane topology.

  • Protease protection assays: These assays can identify regions of the protein exposed to either side of the membrane.

  • Computational prediction algorithms: Tools like TMHMM, HMMTOP, and Phobius can provide initial topology predictions to guide experimental design.

  • Site-directed mutagenesis: Systematic replacement of conserved residues with alanine can identify functionally important regions and their membrane accessibility .

How does I. loihiensis Lgt compare functionally with Lgt homologs from other bacterial species?

While direct complementation data for I. loihiensis Lgt is not provided in the search results, we can infer potential functional characteristics based on comparative studies of other Lgt homologs. Functional complementation studies have shown significant variability among Lgt homologs from different bacterial species. For example, Lgt from E. coli, Haemophilus influenzae, and Helicobacter pylori successfully complement Lgt deficiency in E. coli, while homologs from Neisseria gonorrhoeae, Salmonella enterica, and Acinetobacter baumannii show limited or no complementation .

The table below summarizes the complementation abilities of various Lgt homologs:

Bacterial SourceComplementation in E. coliGrowth/Morphology Effects
E. coliStrongNormal
H. influenzaeStrongNormal
H. pyloriModerateSmall colony phenotype
P. aeruginosaWeakNormal
S. entericaVery limitedDelayed growth, abnormal morphology
A. baumanniiVery limitedDelayed growth, abnormal morphology
N. gonorrhoeaeNoneOnly reaches exponential phase, abnormal morphology

What evolutionary patterns are observed in Lgt conservation across bacterial species?

Lgt is highly conserved across bacterial species, with several invariant residues in the signature motif that are critical for function . The recent research indicates that "arm" and "head" domains in Lgt determine functional diversity among bacterial pathogens . Evolutionary analysis suggests that while the catalytic core of Lgt is well conserved, variations in auxiliary domains may have evolved to accommodate species-specific substrate preferences or membrane environments.

Interestingly, the distribution of Lgt substrates varies across bacterial lineages. For example, Lpp (Braun's lipoprotein), a critical substrate of Lgt in E. coli, is restricted to a subclade of γ-proteobacteria . This suggests co-evolution between Lgt and its lipoprotein substrates, potentially explaining why Lgt homologs from certain species cannot functionally substitute for others despite high sequence similarity.

How do structural differences in Lgt across species impact substrate specificity?

The structural variations in Lgt homologs, particularly in the "arm" and "head" domains, likely influence substrate recognition and processing efficiency . These differences may explain why closely related Lgt homologs can exhibit dramatically different complementation abilities. For instance, despite being a close homolog of E. coli Lgt, the S. enterica homolog does not restore morphology and viability in an E. coli Δlgt strain .

Factors that may influence substrate specificity include:

  • Membrane topology and positioning of catalytic residues

  • Specific amino acid differences in substrate binding regions

  • Interactions with species-specific membrane components

  • Differences in quaternary structure or protein-protein interactions

  • Variations in the "arm" and "head" domains that determine recognition of specific lipobox motifs

Research into these structural determinants could provide insights for engineering Lgt variants with modified substrate specificity for biotechnological applications.

What are the major technical challenges in expressing and purifying active I. loihiensis Lgt?

As a transmembrane protein, I. loihiensis Lgt presents several challenges for expression and purification:

  • Membrane protein solubility: Appropriate detergents or amphipols must be selected to maintain protein stability and activity once extracted from the membrane.

  • Expression system optimization: While E. coli is commonly used (as noted for the commercial preparation) , optimizing expression conditions is critical to prevent protein aggregation or misfolding.

  • Maintaining native conformation: The presence of seven transmembrane segments makes it challenging to preserve the native structure during purification.

  • Tag interference: Although N-terminal 10xHis-tagging facilitates purification , the tag may potentially interfere with enzymatic activity or membrane insertion, requiring validation of the tagged protein's functionality.

  • Activity assessment: Developing reliable in vitro assays to confirm that the purified enzyme maintains catalytic activity is essential but technically demanding.

These challenges necessitate careful optimization of expression constructs, host strains, induction conditions, and purification protocols to obtain functionally active enzyme for biochemical studies.

How can researchers design experiments to investigate I. loihiensis Lgt substrate specificity?

To investigate the substrate specificity of I. loihiensis Lgt, researchers can employ several complementary approaches:

  • In vivo complementation studies: Determine whether I. loihiensis Lgt can process prelipoproteins from different bacterial species by expressing it in various lgt-deficient backgrounds and assessing lipoprotein modification.

  • In vitro enzymatic assays: Develop assays using synthetic peptides corresponding to different lipobox sequences to quantitatively assess substrate preferences.

  • Chimeric enzyme construction: Create chimeric proteins between I. loihiensis Lgt and other Lgt homologs, swapping domains to identify regions responsible for substrate specificity.

  • Site-directed mutagenesis: Systematically mutate conserved and variable residues to map the substrate-binding site and catalytic mechanism.

  • Structural biology approaches: Attempt crystallization or cryo-EM studies of I. loihiensis Lgt in complex with substrate analogs to directly visualize substrate-enzyme interactions.

These approaches would provide insights into both the fundamental enzymology of I. loihiensis Lgt and potential biotechnological applications for specific lipoprotein modifications.

What are promising research directions for utilizing I. loihiensis Lgt in antimicrobial drug development?

Given the essential nature of Lgt in many bacteria and its absence in eukaryotes, I. loihiensis Lgt and its homologs represent attractive targets for antimicrobial drug development:

  • Structure-based inhibitor design: With increasing structural information about Lgt proteins, rational design of inhibitors targeting the active site or substrate-binding pocket becomes feasible.

  • High-throughput screening: Development of activity assays suitable for screening chemical libraries could identify lead compounds for further optimization.

  • Cross-species inhibition profiling: Comparing inhibitor effectiveness against Lgt from different pathogens could identify broad-spectrum or species-selective compounds.

  • Resistance mechanism studies: Investigating potential resistance mechanisms through directed evolution experiments could inform inhibitor design strategies.

  • Combination therapy approaches: Exploiting synergies between Lgt inhibitors and other antimicrobials, particularly those targeting cell envelope integrity, might enhance effectiveness.

The critical role of Lgt in bacterial viability, demonstrated by complementation studies showing its essentiality in E. coli , underscores its potential as an antimicrobial target, particularly for developing novel strategies against antibiotic-resistant pathogens.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.